2.5% and 10% Phenylephrine for Mydriasis in Diabetic Patients With Darkly Pigmented Irides
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
To compare the clinical efficacy and systemic side effects between 2.5% and 10% phenylephrine
for mydriasis in diabetic patient with darkly pigmented irides.